Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from MedAdvisor Limited ( (AU:MDR) ).
MedAdvisor Limited has announced the issuance of 19,826,251 unquoted securities under an employee incentive scheme, which are not intended to be quoted on the ASX. This move is part of the company’s strategy to incentivize employees, potentially impacting its operational dynamics and aligning staff interests with company growth objectives.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, providing digital solutions to enhance medication management and adherence. The company focuses on improving patient outcomes by offering platforms that connect patients with healthcare providers and pharmacies.
Average Trading Volume: 1,053,610
Technical Sentiment Signal: Sell
Current Market Cap: A$36.26M
Learn more about MDR stock on TipRanks’ Stock Analysis page.